LOXL4 and hepatocellular carcinoma: found that lysyl oxidase-like 4 (LOXL4) could promote immune evasion in hepatocellular carcinoma cells, which can be eliminated by abolishing LOXL4-mediated PD-L1 presentation by copper chelators (16).